SCHEMBL2407694

SCHEMBL2407694

CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](Oc2cc(Br)ccc2Cl)SC[C@H]1OC(C)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 2/20 0.33
PTPN1 P18031 2/20 0.33
PTPN6 P29350 1/20 0.33
ERBB2 P04626 1/20 0.32
EPHA2 P29317 1/20 0.32
KDR P35968 1/20 0.32
EPHB4 P54760 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.31
PTPRF P10586 1/20 0.31
LMNA P02545 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
RECQL P46063 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407692 1.00 PTPN2 (0.33) PTPN2PTPN1PTPN6ERBB2EPHA2
SCHEMBL2410710 0.86 PTPN2 (0.33) PTPN2PTPN1PTPN6PTPRF
SCHEMBL2410712 0.86 PTPN2 (0.33) PTPN2PTPN1PTPN6PTPRF
SCHEMBL2415123 0.84 PTPN2 (0.33) PTPN2PTPN1PTPN6MEN1KMT2A
SCHEMBL2415119 0.84 PTPN2 (0.33) PTPN2PTPN1PTPN6MEN1KMT2A
SCHEMBL314645 0.82 OPRK1 (0.32)
SCHEMBL314644 0.82 OPRK1 (0.32)
SCHEMBL2414104 0.82 KMO (0.34) MAPK1MAPT
SCHEMBL2414100 0.82 KMO (0.34) MAPK1MAPT
SCHEMBL2407398 0.82 KMO (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013010-B2 5-thioxylopyranose compounds LABORATOIRES FOURNIER S.A. (FR) 2011-09-06 US disclosed
US-20090186840-A1 5-Thioxylopyranose Compounds LABORATOIRES FOURNIER S.A (FR) 2009-07-23 US disclosed
EP-2066681-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER SA (FR) 2009-06-10 EP disclosed
WO-2008037923-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER S.A. (FR) 2008-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186840-A1 5-Thioxylopyranose Compounds TPMT, PNPO, CYP3A5 PTPN2 509/4885PTPN1 379/4885PTPN6 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.